As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
We are very excited to launch our new website! Please take a few moments to click around and explore...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...